Eli Lilly will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief Executive Officer Dave Ricks said. He spoke with David Rubenstein at a meeting of the Economics Club in Washington DC

See omnystudio.com/listener for privacy information.